Supravenous discoloration of the skin due to docetaxel treatment.
Schrijvers
D
D
Van Den Brande
J
J
Vermorken
J B
JB
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives*; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel